Tata India Pharma & Healthcare Fund Direct Growth

Tata India Pharma & Healthcare Fund Direct Growth: NAV ₹39.85, 3Y return 18.38%, 5Y 15.80%, AUM ₹1,541 Cr, expense ratio 1.09%, iNVESTT rating 4/5. Returns vs index, rolling returns, holdings, Direct vs Regular and peers, by a SEBI Registered Research Analyst.

Key facts

NAV
₹39.8534 (19 Nov 2026)
1-year return
10.72%
3-year return (CAGR)
18.38%
5-year return (CAGR)
15.80%
Fund size (AUM)
₹1,541 Cr
Expense ratio
1.09%
Exit load
0.25% of NAV if redeemed /switched out before 30 days from the date of allotment.
Minimum investment
Rs.5000 & in multiples of Re.1/- thereafter.
Category
Sectoral Fund
Benchmark
BSE Healthcare TRI
Riskometer
Very High Risk
Fund manager
Rajat Srivastava
Launch date
4 Dec 2015
iNVESTT rating
4 out of 5

Frequently asked questions

What is the NAV of Tata India Pharma & Healthcare Fund Direct Growth today?

The NAV of Tata India Pharma & Healthcare Fund Direct Growth is ₹39.8534 as of 19 Nov 2026.

What are the returns of Tata India Pharma & Healthcare Fund Direct Growth?

10.72% over 1 year, 18.38% a year over 3 years, 15.80% a year over 5 years. Past returns do not guarantee future returns; compare them with the benchmark and rolling returns on this page.

What is the expense ratio of Tata India Pharma & Healthcare Fund Direct Growth?

The expense ratio (TER) is 1.09% a year.

What is the AUM (fund size) of Tata India Pharma & Healthcare Fund Direct Growth?

Tata India Pharma & Healthcare Fund Direct Growth manages ₹1,541 Cr.

Is there an exit load on Tata India Pharma & Healthcare Fund Direct Growth?

Exit load: 0.25% of NAV if redeemed /switched out before 30 days from the date of allotment..

How risky is Tata India Pharma & Healthcare Fund Direct Growth?

Its SEBI riskometer is "Very High Risk" and it is in the Sectoral Fund category.

What is the benchmark of Tata India Pharma & Healthcare Fund Direct Growth?

The benchmark is BSE Healthcare TRI. This page compares the fund with its benchmark's total-return index (TRI).

What is the iNVESTT rating of Tata India Pharma & Healthcare Fund Direct Growth?

4 out of 5. iNVESTT rating: where the fund ranks in its category over 1, 3 and 5 years (3 and 5 years count most). Top fifth = 5 stars. A past-performance measure, not a recommendation.

Research by iNVESTT, a SEBI Registered Research Analyst (INH000010858). Data from AMFI. Mutual fund investments are subject to market risks; past performance does not guarantee future returns.

Mutual fund research · Fund screener · Compare this fund · SIP calculator · Personal advisory